Recombinant Humanized Anti-HER2 Antibody (Herceptin™) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts1
Cancer Res (1998) 58 (13): 2825–2831.
Currently there are no citedby results. Try again later.